Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Chokri Ben Lamine: High-Yield Pearls from a Heme Perspective on Uremic Coagulopathy
AI generated
May 2, 2026, 15:15

Chokri Ben Lamine: High-Yield Pearls from a Heme Perspective on Uremic Coagulopathy

Chokri Ben Lamine,  Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on X:

“Uremic Coagulopathy — High-Yield Pearls (Heme Perspective)

  • Pathophysiology is platelet dysfunction (not factor deficiency)
  • Mechanism is impaired platelet adhesion with aggregation
  • Key toxins include guanidinosuccinic acid, phenols, PTH
  • Decreased vWF interaction leads to defective GP Ib–vWF binding
  • Platelet count is usually normal
  • PT/PTT is usually normal
  • Bleeding time and PFA-100 is prolonged

Clinical picture

  • Mucocutaneous bleeding (epistaxis, gingival)
  • Easy bruising, petechiae
  • GI bleeding common
  • Increased Post-procedure bleeding risk

Triggers worsening bleeding

  • Uremia (BUN 60–80 mg/dL)
  • Anemia ( Decreased Hct worsens platelet function)
  • Concomitant antiplatelets NSAIDs
  • Dialysis delay

Diagnosis (clinical)

  • CKD/ESRD context
  • Normal coagulation profile
  • Platelet dysfunction pattern
  • Exclusion of DIC/liver disease

Management (stepwise — guideline-based)

1.Dialysis is definitive

  • Rapid improvement within 24–48h
  • First-line in active bleeding

2.DDAVP (Desmopressin)

  • 0.3 mcg/kg IV over 20–30 min
  • Onset – 1–2 h
  • Duration – 6–8 h
  • Tachyphylaxis after 1–2 doses

3.Correct anemia

  • Target Hb 10 g/dL
  • RBC transfusion improves platelet interaction

4.Cryoprecipitate

  • If bleeding persists
  • Works via vWF fibrinogen
  • Effect within hours

5.Conjugated estrogens

  • 0.6 mg/kg IV daily 5 days
  • Delayed onset (6–24 h)
  • Longer effect (1–2 weeks)

Avoid

  • Platelet transfusion (limited role unless thrombocytopenia)
  • NSAIDs aspirin

Practical procedural prep

  • Dialyze pre-procedure
  • Give DDAVP 30–60 min before
  • Ensure Hb optimized
  • Consider cryo if high-risk

Evidence pearls

  • DDAVP is transient but effective (standard of care for urgent bleeding)
  • Dialysis is cornerstone (KDIGO CKD guidelines)
  • Estrogens are useful in recurrent bleeding when dialysis insufficient

MCQ

Patient with ESRD and epistaxis and normal PT and PTT:

What is the best immediate therapy?

  1. FFP
  2. Platelets
  3. DDAVP
  4. Vitamin K

Answer:

C (DDAVP) — fastest hemostatic correction

OSCE scenario

ESRD patient needs central line

Plan:

Perform dialysis, then administer DDAVP pre-procedure, optimize hemoglobin, and avoid NSAIDs”

Other posts featuring Chokri Ben Lamine on Hemostasis Today.

anemia Aspirin Blood Chokri Ben Lamine CKD cryoprecipitate DDAVP Desmopressin Dialysis DIC ESRD GI Bleeding guanidinosuccinic acid Health Hematocrit Hematology Heme Hemostasis Hemostasis News Hemostasis Today Medicine Mucocutaneous bleeding NSAIDs Petechiae phenols Platelet Platelet dysfunction PT PTH PTT RBC Tachyphylaxis Uremia Uremic Coagulopathy VWF
NewsFeed